Aligos Therapeutics Inc. (ALGS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aligos Therapeutics Inc.

    NASDAQ: ALGS · Real-Time Price · USD
    11.34
    0.60 (5.59%)
    At close: Sep 05, 2025, 3:59 PM
    11.17
    -1.50%
    After-hours: Sep 05, 2025, 04:33 PM EDT

    Aligos Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 3.94M 15.53M 13.91M 4.36M
    Cost of Revenue
    		 n/a 3.07M 3.67M 104.15M
    Gross Profit
    		 3.94M 12.46M 10.23M -99.79M
    Operating Income
    		 -89.15M -88.13M -97.58M -128.32M
    Interest Income
    		 n/a 1.24M 1.64M 132K
    Pretax Income
    		 -130.88M -86.88M -95.94M -128.19M
    Net Income
    		 -131.21M -87.68M -96.05M -128.33M
    Selling & General & Admin
    		 22.83M 30.62M 26.41M 28.53M
    Research & Development
    		 70.27M 73.04M 85.08M 104.15M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 93.1M 103.66M 111.49M 132.68M
    Interest Expense
    		 n/a n/a 1.64M 132K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 93.1M 102.96M 111.49M 132.68M
    Income Tax Expense
    		 331K 795K 106K 143K
    Shares Outstanding (Basic)
    		 6.26M 24.87M 42.7M 39.86M
    Shares Outstanding (Diluted)
    		 6.26M 24.87M 42.7M 39.86M
    EPS (Basic)
    		 -20.94 -3.52 -2.25 -3.22
    EPS (Diluted)
    		 -20.94 -3.52 -2.25 -3.22
    EBITDA
    		 -89.15M -85.06M -93.91M -124.54M
    EBIT
    		 -89.15M -88.13M -97.58M -128.32M
    Depreciation & Amortization
    		 n/a 3.07M 3.67M 3.78M

    Add to Watchlist